Physician

Adeep Thumar, M.D.

According to 2025 Medicare claims, Adeep Thumar, M.D. (NPI: 1245425495) practices urology in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07039-4896. Thumar is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Thumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,004 traditional Medicare patients, billed 4,214 HCPCS/CPT codes, and received $268,444 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,581 prescription claims across 903 beneficiaries totaling $512,723 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 150 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $68,226 to $268,444. Similarly, Part D prescription costs have moved sharply higher in recent years, from $36,472 to $512,723. In contrast, DME billing represents a smaller volume and rose steadily, from $101 to $1,169.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	170	961	$68,226
2016	316	2,533	$154,398
2017	513	3,227	$161,127
2018	595	4,334	$235,218
2019	547	5,179	$242,981
2020	588	3,396	$205,664
2021	620	4,553	$227,445
2022	729	4,677	$225,499
2023	871	4,855	$282,655
2024	1,004	4,214	$268,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	308	$36,472
2016	198	655	$128,768
2017	322	975	$102,250
2018	381	1,391	$176,201
2019	413	1,637	$175,007
2020	446	1,821	$197,072
2021	487	2,003	$229,586
2022	586	2,258	$279,488
2023	748	2,823	$393,572
2024	903	3,581	$512,723

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	25	$6,535
2016	N/R	33	$8,982
2017	N/R	67	$19,588
2018	N/R	83	$27,239
2019	N/R	91	$43,653
2020	N/R	72	$29,765
2021	N/R	126	$31,540
2022	N/R	151	$33,613
2023	N/R	167	$43,893
2024	N/R	150	$38,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	136	136	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	601	822	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	312	433	$72
51798	Ultrasound measurement of bladder capacity after voiding	190	200	$10
81003	Automated urinalysis test	333	392	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	370	20,274	$295,492
Gemtesa	Vibegron	77	5,109	$79,625
Tamsulosin Hcl	Tamsulosin Hcl	857	72,950	$16,643
Potassium Citrate Er	Potassium Citrate	132	9,351	$15,341
Silodosin	Silodosin	149	11,991	$15,086

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	29	$19,588
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	39	$13,317
A5054	Ostomy pouch, closed; for use on barrier with flange (2 piece), each	N	N/R	11	$1,268
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	11	$1,216
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	11	$1,199

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adeep Thumar, M.D.?

Tedicare shows public-source Medicare data for Adeep Thumar, M.D. (NPI 1245425495), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adeep Thumar, M.D. have ACO affiliation data?

Adeep Thumar, M.D. is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Adeep Thumar, M.D.?

Adeep Thumar, M.D. is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Adeep Thumar, M.D. have Open Payments data?

Adeep Thumar, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.